Previous 10 | Next 10 |
NEW YORK, NY / ACCESSWIRE / February 28, 2024 / Bernstein Liebhard LLP: Do you, or did you, own shares of InMode Ltd. (NASDAQ:INMD)? Did you purchase your shares between June 4, 2021 and October 12, 2023, inclusive? Did you lose money in your investment in InMode Ltd.? Do you want to...
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In InMode To Contact Him Directly To Discuss Their Options New York, New York--(Newsfile Corp. - February 27, 2024) - Faruqi & Faruqi, LLP, a leading nationa...
SAN FRANCISCO, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Hagens Berman urges InMode Ltd. (NASDAQ: INMD) investors who purchased during the class period and suffered at least $100,000 in losses to submit your losses now . Class Period: June 4, 2021 – Oct. 12, 2023 Lead Plaintiff...
2024-02-21 02:32:38 ET Summary Inmode, after years of rapid growth, seems to be entering a scenario of revenue stagnation. The uncertainties about future demand, the company's ability to launch new products, uncertainties about acquisitions, and the board's inefficiency in allocat...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages INMD Investors Who Suffered $100K Losses to Contact Firm's Attorneys SAN FRANCISCO, CA / ACCESSWIRE / February 20, 2024 / Hagens Berman urges InMode Ltd. (NASDAQ:INMD) investors who purchased during the class period and suffered at least ...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In InMode To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in InMode stock or options between June 4, 2021, and October 12, 2023 and...
HAGENS BERMAN, NATIONAL TRIAL ATTORNEYS, Encourages INMD Investors Who Suffered $100K Losses to Contact Firm's Attorneys San Francisco, California--(Newsfile Corp. - February 16, 2024) - Hagens Berman urges InMode Ltd. (NASDAQ: INMD) investors who purchased during the class period and suffered...
2024-02-16 11:30:40 ET Summary InMode beats revenue and EPS estimates in Q4 2023 earnings report. Q4 revenue is down 5% YoY and non-GAAP EPS is down 9% YoY. InMode maintains impressive gross margin of 84% and sees 20% YoY growth in revenue from consumables and services. De...
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In InMode To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 investing in InMode stock or options between June 4, 2021 and October 12, 2023 and ...
NEW YORK, NY / ACCESSWIRE / February 14, 2024 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of INMODE LTD. ("InMode" or "the Company") (NASDAQ:INMD). Investors who purchased InMode securities are encouraged to obtain additional information and...
News, Short Squeeze, Breakout and More Instantly...
Morpheus8 Secures First and Only FDA Clearance for Soft Tissue Contraction for Fractional Radiofrequency Microneedling PR Newswire IRVINE, Calif. , July 17, 2024 /PRNewswire/ -- InMode Ltd. (NASDAQ: INMD), a leading global provider of innovative medical technolog...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 5.6% to $127.4 on volume of 368,729,821 shares Maxeon Solar Technologies Ltd. (MAXN) rose 14.2% to $0.2407 on volume of 294,399,898 shares Kazia Therapeutics Limited (KZIA) rose 85.6% to $1.24 on volume ...
A look at the top 10 most actives in the United States Kazia Therapeutics Limited (KZIA) rose 106.5% to $1.38 on volume of 71,739,314 shares Renalytix plc (RNLX) rose 41.4% to $0.4269 on volume of 54,892,134 shares Maxeon Solar Technologies Ltd. (MAXN) fell 7.4% to $0.1951 on volume of 45...